Failure of clinical practice guidelines to meet institute of medicine standards: Two more decades of little, if any, progress.

作者: Justin Kung , Ram R. Miller , Philip A. Mackowiak

DOI: 10.1001/2013.JAMAINTERNMED.56

关键词: GovernmentMedicineFamily medicineNational Guideline ClearinghouseAlternative medicineMEDLINEInformation scientistEvidence-based medicineSelect committeeSubspecialty

摘要: Background In March 2011, the Institute of Medicine (IOM) issued a new set standards for clinical practice guidelines intended to enhance quality being produced. To our knowledge, no systematic review adherence such has been undertaken since one published over decade ago. Methods Two reviewers independently screened 130 selected at random from National Guideline Clearinghouse (NGC) website compliance with 18 25 IOM standards. Results The overall median number (percentage) satisfied (out 18) was 8 (44.4%), an interquartile range 6.5 (36.1%) 9.5 (52.8%). Fewer than half surveyed met more 50% Barely third produced by subspecialty societies surveyed. Information on conflicts interest (COIs) given in fewer Of those including information, COIs were present two-thirds committee chairpersons (71.4%) and 90.5% co-chairpersons. Except US government agency–produced guidelines, criteria used select members selection process rarely described. Committees developing included information scientist or patient representative. Non-English literature, unpublished data, and/or abstracts considered guidelines; differences opinion among generally not aired benefits recommendations enumerated often potential harms. Guidelines 2006 through 2011 varied little regard average satisfied. Conclusion Analysis sample archived NGC as June demonstrated poor standards, if any improvement past 2 decades.

参考文章(20)
Michelle Mancher, Dianne Miller Wolman, Sheldon Greenfield, Robin Graham, Earl Steinberg, Clinical Practice Guidelines We Can Trust ,(2013)
Wendy L. Bennett, Olaide A. Odelola, Lisa M. Wilson, Shari Bolen, Saranya Selvaraj, Karen A. Robinson, Eric B. Bass, Milo A. Puhan, Evaluation of Guideline Recommendations on Oral Medications for Type 2 Diabetes Mellitus: A Systematic Review Annals of Internal Medicine. ,vol. 156, pp. 27- 36 ,(2012) , 10.7326/0003-4819-156-1-201201030-00005
Terrence M. Shaneyfelt, Robert M. Centor, Reassessment of Clinical Practice Guidelines JAMA. ,vol. 301, pp. 868- 869 ,(2009) , 10.1001/JAMA.2009.225
M Cynthia, CM Boyd, J Darer, C Boult, LP Fried, L Boult, AW Wu, Clinical Practice Guidelines and Quality of Care for Older Patients With Multiple Comorbid Diseases JAMA. ,vol. 294, pp. 716- 724 ,(2005) , 10.1001/JAMA.294.6.716
Otis Brawley, Tim Byers, Amy Chen, Michael Pignone, David Ransohoff, Maryjean Schenk, Robert Smith, Harold Sox, Alan G. Thorson, Richard Wender, New American Cancer Society Process for Creating Trustworthy Cancer Screening Guidelines JAMA. ,vol. 306, pp. 2495- 2499 ,(2011) , 10.1001/JAMA.2011.1800
Christine Laine, Darren B. Taichman, Cynthia Mulrow, Trustworthy clinical guidelines. Annals of Internal Medicine. ,vol. 154, pp. 774- 775 ,(2011) , 10.7326/0003-4819-154-11-201106070-00011
Allan D. Sniderman, Why Guideline-Making Requires Reform JAMA. ,vol. 301, pp. 429- 431 ,(2009) , 10.1001/JAMA.2009.15
Leonard Pogach, David C Aron, Sudden Acceleration of Diabetes Quality Measures JAMA. ,vol. 305, pp. 709- 710 ,(2011) , 10.1001/JAMA.2011.153